Literature DB >> 558926

PCC4, a new cell surface antigen common to multipotential embryonal carcinoma cells, spermatozoa, and mouse early embryos.

G Gachelin, R Kemler, F Kelly, F Jacob.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 558926     DOI: 10.1016/0012-1606(77)90365-7

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


× No keyword cloud information.
  7 in total

Review 1.  Pluripotent stem cell lines.

Authors:  Junying Yu; James A Thomson
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

2.  Overt expression of H-2 serotypes on EC cells is not necessary for host rejection.

Authors:  L J Maher; W F Dove
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  Monoclonal antibodies reacting with murine teratocarcinoma cells.

Authors:  P N Goodfellow; J R Levinson; V E Williams; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

4.  The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3.

Authors:  P R Avner; W F Dove; P Dubois; J A Gaillard; J L Guénet; F Jacob; H Jakob; A Shedlovsky
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

5.  Cullin4B/E3-ubiquitin ligase negatively regulates beta-catenin.

Authors:  Rachana Tripathi; Satya Keerthi Kota; Usha K Srinivas
Journal:  J Biosci       Date:  2007-09       Impact factor: 1.826

6.  Spontaneous tumors in long-term--vasectomized mice. Increased incidence and association with antisperm immunity.

Authors:  D J Anderson; N J Alexander; D L Fulgham; J L Palotay
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

7.  Detection of the circulating antibodies to teratocarcinomadefined antigens in patients with testicular tumours.

Authors:  J Teodorczyk-Injeyan; M A Jewett; C A Burke; S Ostrand-Rosenberg
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.